Ceribell
NASDAQ: CBLL4 known investors
Ceribell develops a point-of-care EEG system that uses AI to detect seizure activity, including status epilepticus, in patients. The device is used by clinicians in hospital and ICU settings to enable faster EEG assessment and improve patient outcomes.
Founders & leadership
JT
Joseph TaylorDirector
SB
Scott BlumbergExecutive Officer
LI
Lucian IancoviciDirector
RW
Raymond WooExecutive Officer
JP
Josef ParviziDirector
DS
David StoffelExecutive Officer
XC
Xingjuan ChaoExecutive Officer, Director
WB
William BurkeDirector
JT
Julie Tammenoms BakkerDirector
RR
Rebecca RobertsonDirector
DR
Dan RogyExecutive Officer
Investors · 4
Reported raises · per SEC filings
Form D private placements▶$102.5MraisedSep 2022 · 17 investors · Other Health CareRule 506(b)
▶$102.5MraisedSep 2022 · 17 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Joseph TaylorDirector
- Scott BlumbergExecutive Officer
- Lucian IancoviciDirector
- Raymond WooExecutive Officer
- Josef ParviziDirector
- David StoffelExecutive Officer
- Xingjuan ChaoExecutive Officer, Director
- William BurkeDirector
- Julie Tammenoms BakkerDirector
- Rebecca RobertsonDirector
- Dan RogyExecutive Officer
- Offering amount
- $102.5M
- Amount sold
- $102.5M
- First sale
- Apr 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.